Gene Editing Tools Market Application and Innovation Analysis 2019 | Thermo Fisher Scientific Inc., ERS Genomics, CRISPR THERAPEUTICS, Merck KGaA, Editas Medicine, Takara Bio USA

According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 258 Mn in terms of value in 2018. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18% during the period 2019-2029.

The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9) segment is a leading segment in terms of revenue by product type in the gene editing tools market, and accounted for an approximate revenue share of 75% in 2018. CRISPR/Cas9 gene editing tools are most widely used by scientists to create transgenic animals that include zebrafish, pigs, mice, rats, and primates. Among all the distribution channels in the gene editing tools market, the academic and research institutes segment is expected to be most prominent segment, followed by biotech and pharmaceutical companies.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9544

Prevalence of Cancers and Rare Genetic Diseases Establish a Strong Base for Innovation of Gene Editing Tools

The rising prevalence of cancer and other genetic disorders, such as sickle cell disease, heart disease, diabetes, Alzheimer's disease, obesity, and others, is among the key factors impacting the growth of gene editing tools market. Cancer is registered to be the second most prominent cause of death worldwide. According to the World Health Organization (WHO), the number of deaths due to cancer worldwide in 2015 was 8.8 million. However, cancer alone was responsible for an estimated 9.6 million deaths globally in 2018.

Worldwide, approximately about 1 in 6 deaths occur owing to cancer. An analysis states that approximately 70% of deaths due to cancer occur in low- and middle-income countries. Thus, gene editing is most preferred for the management of rare genetic disorders, which is driving the demand for gene editing, thus generating a favourable revenue opportunity for gene editing tools.

The growing prevalence and incidence of rare genetic disorders, majorly Sickle Cell Disease (SKD), cancer, and Alzheimer's disease, is leading to the high demand for genome editing, and is one of the leading factors that is contributing significantly to the growth of the gene editing tools market. Moreover, gene editing tools, such as CRISPR, TALENs, and ZFNs, find precise applications in the treatment of cancer. Owing to the high efficiency and accuracy of the CRISPR-Cas9 gene editing technique, it has emerged as a potential tool for cancer therapy. Among its various applications, CRISPR-Cas9 has a high clinical potential to detect novel target genes for cancer therapy.

Biomedical Community Eyes Potential Application of Gene Editing Tools

Introduction of technologically advanced gene editing tools is expected to boost the growth of gene editing tools market. Recent advancements in CRISPR gene editing tools and their ease of use have generated significant interest in the biomedical community. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based gene editing has high potential to cater to the therapeutic landscape of induced disorders, owing to the presence of key players in the industry such as Intellia, CRISPR Therapeutics, and Editas. CRISPR gene editing tools offer precise gene-targeted treatments for ?-thalassemia and SKD. Among gene editing tools, there are potential applications for CRISPR in the gene editing tools market in human therapeutics as well as veterinary therapeutics.

Regional Players Focusing on Product Reach & Connectivity

North America, followed by Europe, is a prominent region in the global gene editing tools market. North America accounts for a revenue share of about 25.0% in 2018 in gene editing tools market. Europe accounting for the second-largest revenue share, and is followed by South Asia in the gene editing tools market. India, China, and Japan are among the emerging markets in the gene editing tools market. Japan is among the fastest-growing emerging markets in the global gene editing tools market, and is projected to grow at a CAGR of more than 6% during the forecast period of 2018-2028.

Request to Browse Report Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-9544

The gene editing tools market report tracks some of the key companies operating in gene editing tools market, such as Thermo Fisher Scientific Inc., ERS Genomics, CRISPR THERAPEUTICS, Merck KGaA, Editas Medicine, Takara Bio USA, New England Biolabs, Intellia Therapeutics, Inc., and GenScript Biotech Corporation. Majority of the key regional players in the gene editing tools market are focused on increasing their product reach and connectivity with the help of domestic distributors of gene editing tools. Moreover, the manufacturers of gene editing tools are focused to strengthening their businesses in high-growth markets, such as India, Japan, China, and Argentina, by expanding their sales and distribution channels across these countries.

Gene Editing Tools Market Reports - Table of Contents
1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Products Innovation / Key Development Trends

3.3. Product Strategies by Key Manufacturers

4. Key Success Factors

4.1. Gene Editing Tools Product Adoption / Usage Analysis

4.2. Demand for Animal Productivity, Breeding and Therapeutics

4.3. Demand for Livestock Products

4.4. Advancement in Bioremediation and Waste Management

5. Global Gene Editing Tools Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Market Background

6.1. Macro-Economic Factors

6.1.1. Global GDP Growth Outlook

6.1.2. Global Healthcare Expenditure Outlook

6.1.3. R&D Investment Outlook

6.2. Forecast Factors - Relevance & Impact

6.2.1. Increase in R&D Funding and Grants

6.2.2. Increase in Number of Patents Filed

6.2.3. New Product Launches

6.2.4. Investment by Venture Capitalists in Early Stage Biotechs

6.3. Market Dynamics

6.3.1. Drivers

6.3.2. Restraints

6.3.3. Opportunity Analysis

7. Application of Gene Editing Tools in Emerging Areas – Review

7.1. Introduction

7.2. Market Size (US$ Mn) Analysis and Forecast 2019-2029, by Application Area

7.2.1. Veterinary Medicine

7.2.1.1. Animal Therapeutic Products

7.2.1.2. Animal Vaccine Products

7.2.2. Genetic Engineering for Livestock Improvement

7.2.3. Synthetic Biology

7.2.4. Bioremediation

7.2.5. Biosecurity

7.3. Penetration of Gene Editing Tools (%), by Emerging Application Areas

7.3.1. Veterinary Medicine

7.3.2. Genetic Engineering for Livestock Improvement

7.3.3. Synthetic Biology

7.3.4. Bioremediation

7.3.5. Biosecurity

7.4. Penetration of CRISPR (%), by Emerging Application Areas

7.4.1. Veterinary Medicine

7.4.2. Genetic Engineering for Livestock Improvement

7.4.3. Synthetic Biology

7.4.4. Bioremediation

7.4.5. Biosecurity

Need more information about Report methodology @ https://www.futuremarketinsights.com/askus/rep-gb-9544

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Web: https://www.futuremarketinsights.com/

This release was published on openPR.